Silicon Investor (SI) -- The First Internet Community

STOCKTALK

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor. We ask that you disable ad blocking while on Silicon Investor in the best interests of our community. If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.

Biotech / Medical : GUMM - Eliminate the Common Cold -- Ignore unavailable to you. Want to Upgrade?

To: Hank who wrote (2643)	10/17/2000 7:55:29 PM
From: DanZ	Read Replies (1) \| Respond to of 5582

I agree with your comments regarding prescription drugs. I just don't think that it has anything to do with Zicam, or any other OTC medicine. Companies that sell established OTC drugs (Tylenol, Contac, Alka Seltzer, etc) don't spend more in advertising than they generate in sales. Who cares how much money drug companies spend promoting prescription drugs? It isn't related to the discussion here. One reason that prescription drugs are so expensive is because of the amount that companies spend on promotion. Despite that, they still make a profit over the life cycle of the drug in most cases. Your predictions about Gum Tech's financials have never been close to reality and you have been wrong about a host of other issues related to this company. Therefore the rest of your comments belong in the trash can and show a gross ignorance of sound financial analysis. Bye!